Company
Headquarters: LA Jolla, CA, United States
Employees: 138
CEO: Mr. Andrew Spaventa
$31.6 Million
USD as of Jan. 1, 2024
Company | Market Cap (USD) |
---|---|
Intuitive Surgical, Inc. | $113.81 B |
EssilorLuxottica SA | $90.57 B |
Becton, Dickinson and Company | $70.33 B |
HOYA Corp | $43.39 B |
Alcon Inc. | $37.65 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. It manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits; and offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution. The company was incorporated in 2016 and is headquartered in La Jolla, California.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Singular Genomics Systems, Inc. has the following listings and related stock indices.
Stock: NASDAQ: OMIC wb_incandescent